Alliance Global Partners analyst James Molloy upgraded BioCardia (BCDA) to Buy from Neutral with a $6 price target The company recently announced multiple clinical updates regarding its lead CardiAMP ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.69% of ...

Fintel reports that on January 27, 2025, Alliance Global Partners initiated coverage of Palladyne AI (NasdaqGM:PDYN) with a ...

Alliance Global Partners raised the firm’s price target on IperionX (IPX) to $32 from $24.50 and keeps a Buy rating on the shares. The company ...

Fintel reports that on December 18, 2024, Alliance Global Partners upgraded their outlook for Vitesse Energy (NYSE:VTS) from Neutral to Buy. As of December 4, 2024, the average one-year price ...

Alliance Global Partners assumed coverage on shares of Tamboran Resources (NYSE:TBN – Free Report) in a research note published on Tuesday, Ratings reports. The firm issued a buy rating and a $32.00 ...

Fintel reports that on December 11, 2024, Alliance Global Partners initiated coverage of Chatham Lodging Trust - Preferred Stock (NYSE:CLDT.PRA) with a Buy recommendation. There are 9 funds or ...

https://www.tipranks.com/news/the-fly/option-care-health-price-target-raised-to-35-from-30-at-jmp-securities Alliance Global Partners lowered the firm’s price ...

Global Cities Business Alliance is a content partner of Bisnow and have worked with our Studio B team to develop creative content and custom offerings. The Global Cities Business Alliance provides ...

Alliance Global Partners analyst James Molloy upgraded BioCardia (BCDA) to Buy from Neutral with a $6 price target The company recently announced multiple clinical updates regarding its lead ...